undifferentiated pleomorphic sarcoma
Showing 1 - 18 of 18
Undifferentiated Pleomorphic Sarcoma Trial in Iowa City (Palbociclib, Pembrolizumab)
Not yet recruiting
- Undifferentiated Pleomorphic Sarcoma
-
Iowa City, IowaUniversity of Iowa Hospitals & Clinics
Nov 1, 2023
Soft Tissue Sarcoma Adult, Angiosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in Denmark, Norway, Sweden (Propranolol,
Recruiting
- Soft Tissue Sarcoma Adult
- +2 more
-
Aarhus, Denmark
- +3 more
Jul 23, 2023
Sarcoma, Myxofibrosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in United States (Isolated Limb Infusion, Pembrolizumab,
Recruiting
- Sarcoma
- +3 more
- Isolated Limb Infusion
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Nov 21, 2022
Osteosarcoma, Bone Tumor, Bone Sarcoma Trial
Not yet recruiting
- Osteosarcoma
- +25 more
- (no location specified)
Aug 24, 2022
Bone Sarcoma, Osteosarcoma, Ewing Sarcoma Trial in France (Treatment by Regorafenib, Treatment by Placebo)
Recruiting
- Bone Sarcoma
- +6 more
- Treatment by Regorafenib
- Treatment by Placebo
-
Besançon, France
- +15 more
Aug 18, 2022
Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor, Myxofibrosarcoma Trial in Los Angeles (procedure, biological,
Recruiting
- Leiomyosarcoma
- +29 more
- Definitive Surgical Resection
- +3 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Apr 26, 2022
Undifferentiated Pleomorphic Sarcoma Trial in San Francisco (ExAblate 2000/2100 Magnetic Resonance-guided Focused Ultrasound
Recruiting
- Undifferentiated Pleomorphic Sarcoma
- ExAblate 2000/2100 Magnetic Resonance-guided Focused Ultrasound (MRgFUS)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 28, 2022
Dedifferentiated Liposarcoma, Recurrent Dedifferentiated Liposarcoma, Recurrent Undifferentiated Pleomorphic Sarcoma Trial in
Active, not recruiting
- Dedifferentiated Liposarcoma
- +5 more
- Ipilimumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 25, 2022
Soft Tissue Sarcoma Adult, Undifferentiated Pleomorphic Sarcoma, Epithelioid Sarcoma Trial in Bordeaux (Trabectedin)
Recruiting
- Soft Tissue Sarcoma Adult
- +6 more
-
Bordeaux, FranceInstitut Bergonie
Feb 1, 2022
Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma Trial in Providence (Gemcitabine, 9-ING-41,
Withdrawn
- Soft Tissue Sarcoma
- +12 more
- Gemcitabine
- +2 more
-
Providence, Rhode Island
- +1 more
Nov 30, 2021
Melanoma (Excluding Uveal Melanoma), Cervical Carcinoma, Pancreatic Carcinoma Trial in United States (XmAb®23104, Yervoy®
Recruiting
- Melanoma (Excluding Uveal Melanoma)
- +15 more
- XmAb®23104
- Yervoy® (ipilimumab)
-
San Diego, California
- +15 more
Sep 20, 2021
Solid Tumor, Triple-negative Breast Cancer, Gastric Adenocarcinoma Trial in Houston, Chuo-Ku (LY3435151, Pembrolizumab)
Terminated
- Solid Tumor
- +8 more
-
Houston, Texas
- +1 more
Aug 4, 2021
Sarcoma, Alveolar Soft Part Sarcoma, Clear Cell Sarcoma Trial in Warsaw (Hypofractionated radiotherapy, Hyperthermia)
Active, not recruiting
- Sarcoma
- +10 more
- Hypofractionated radiotherapy
- Hyperthermia
-
Warsaw, Mazovian, PolandMaria Sklodowska-Curie Institute - Oncology Center
Jan 27, 2021
Sarcoma, Fibrosarcoma, Leiomyosarcoma Trial in Warsaw (Sequential chemo - 3 courses of AI, Hypofractionated radiotherapy)
Unknown status
- Sarcoma
- +16 more
- Sequential chemotherapy - 3 courses of AI
- Hypofractionated radiotherapy
-
Warsaw, Mazovian, PolandMaria Sklodowska-Curie Institute - Oncology Center
Jan 19, 2021
Soft Tissue Sarcomas, Undifferentiated Pleomorphic Sarcoma Trial in Chang chun (Anlotinib, Toripalimab, Blood Draw)
Not yet recruiting
- Soft Tissue Sarcomas
- Undifferentiated Pleomorphic Sarcoma
- Anlotinib
- +3 more
-
Chang chun, Jilin, ChinaFirst Hospital of Jilin University
Jul 8, 2019